CCM
FOMX

Cribstone Capital Management’s Foamix Pharmaceuticals Ltd. Ordinary Shares FOMX Stock Holding History

Cribstone Capital Management’s Portfolio FOMX Stock Details FOMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-201
Closed -$1K – 423
2019
Q4 		$1K Hold
201
– – ﹤0.01% 372
2019
Q3 		$1K Buy
201
+90
+81% +$253 ﹤0.01% 553
2019
Q2 		$0 Buy
+111
New +$332 ﹤0.01% 696

Cribstone Capital Management's FOMX Position: Q1 2020 in Review

Cribstone Capital Management sold out of Foamix Pharmaceuticals Ltd. Ordinary Shares (FOMX) in Q1 2020, closing a stake of 201 shares — an estimated $1K sold.

Cribstone Capital Management first reported a position in FOMX in Q2 2019 and held it in 3 quarters. The position peaked at $1K in Q4 2019. 3 funds tracked by Wall St. Rank hold FOMX as of Q1 2020.

  • Cribstone Capital Management reported no remaining Foamix Pharmaceuticals Ltd. Ordinary Shares position as of Q1 2020 after selling out during the quarter.
  • Cribstone Capital Management sold 201 Foamix Pharmaceuticals Ltd. Ordinary Shares shares in Q1 2020, an estimated $1K.
  • Cribstone Capital Management first reported a position in Foamix Pharmaceuticals Ltd. Ordinary Shares in Q2 2019 and held it in 3 quarters.
  • Cribstone Capital Management's Foamix Pharmaceuticals Ltd. Ordinary Shares position peaked at $1K in Q4 2019.
  • 3 funds tracked by Wall St. Rank held Foamix Pharmaceuticals Ltd. Ordinary Shares as of Q1 2020.

Based on Cribstone Capital Management's 13F filing for Q1 2020, filed 21 Apr 2020.